These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29635617)

  • 1. Surfactant Dysfunction in ARDS and Bronchiolitis is Repaired with Cyclodextrins.
    Al-Saiedy M; Gunasekara L; Green F; Pratt R; Chiu A; Yang A; Dennis J; Pieron C; Bjornson C; Winston B; Amrein M
    Mil Med; 2018 Mar; 183(suppl_1):207-215. PubMed ID: 29635617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.
    Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W
    Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
    Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
    Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug.
    Gunasekara L; Al-Saiedy M; Green F; Pratt R; Bjornson C; Yang A; Michael Schoel W; Mitchell I; Brindle M; Montgomery M; Keys E; Dennis J; Shrestha G; Amrein M
    J Cyst Fibros; 2017 Sep; 16(5):565-572. PubMed ID: 28599957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracheal acid or surfactant instillation raises alveolar surface tension.
    Nguyen TL; Perlman CE
    J Appl Physiol (1985); 2018 Nov; 125(5):1357-1367. PubMed ID: 29771610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.
    Seeger W; Günther A; Walmrath HD; Grimminger F; Lasch HG
    Clin Investig; 1993 Mar; 71(3):177-90. PubMed ID: 8481620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis.
    Raymondos K; Leuwer M; Haslam PL; Vangerow B; Ensink M; Tschorn H; Schürmann W; Husstedt H; Rueckoldt H; Piepenbrock S
    Crit Care Med; 1999 Jan; 27(1):82-9. PubMed ID: 9934898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
    Häfner D; Ibrahim M; Wollin L; Germann PG
    Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant lavage with lidocaine improves pulmonary function in piglets after HCl-induced acute lung injury.
    Huang TK; Uyehara CF; Balaraman V; Miyasato CY; Person D; Egan E; Easa D
    Lung; 2004; 182(1):15-25. PubMed ID: 14752669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.
    Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A
    Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.
    Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A
    Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Lipid Composition of Surfactant and Lung Tissue in Murine Experimental Malaria-Associated Acute Respiratory Distress Syndrome.
    Scaccabarozzi D; Deroost K; Lays N; Omodeo Salè F; Van den Steen PE; Taramelli D
    PLoS One; 2015; 10(12):e0143195. PubMed ID: 26624290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-mediated surfactant dysfunction is mitigated by surfactant protein A.
    Hiansen JQ; Keating E; Aspros A; Yao LJ; Bosma KJ; Yamashita CM; Lewis JF; Veldhuizen RA
    Biochim Biophys Acta; 2015 Mar; 1848(3):813-20. PubMed ID: 25522687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl-beta-cyclodextrin restores the structure and function of pulmonary surfactant films impaired by cholesterol.
    Gunasekara LC; Pratt RM; Schoel WM; Gosche S; Prenner EJ; Amrein MW
    Biochim Biophys Acta; 2010 May; 1798(5):986-94. PubMed ID: 20018170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury.
    Yamashita CM; Cybulskie C; Milos S; Zuo YY; McCaig LA; Veldhuizen RA
    Can J Physiol Pharmacol; 2016 Jun; 94(6):682-5. PubMed ID: 27096327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.
    Gregory TJ; Longmore WJ; Moxley MA; Whitsett JA; Reed CR; Fowler AA; Hudson LD; Maunder RJ; Crim C; Hyers TM
    J Clin Invest; 1991 Dec; 88(6):1976-81. PubMed ID: 1752956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant content in children with inflammatory lung disease.
    LeVine AM; Lotze A; Stanley S; Stroud C; O'Donnell R; Whitsett J; Pollack MM
    Crit Care Med; 1996 Jun; 24(6):1062-7. PubMed ID: 8681574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome.
    Veldhuizen RA; McCaig LA; Akino T; Lewis JF
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1867-71. PubMed ID: 8520748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary surfactant composition early in development of acute lung injury after cardiopulmonary bypass: prophylactic use of surfactant therapy.
    Haslam PL; Baker CS; Hughes DA; MacNaughton PD; Moat NE; Dewar A; Aggarwal A; Evans TW
    Int J Exp Pathol; 1997 Aug; 78(4):277-89. PubMed ID: 9505939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future.
    Amigoni A; Pettenazzo A; Stritoni V; Circelli M
    Clin Drug Investig; 2017 Aug; 37(8):729-736. PubMed ID: 28510235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.